Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Shuttle Pharma to acquire Molecule.ai to boost cancer drug development with AI.

flag Shuttle Pharma has signed a definitive letter of intent to acquire Molecule.ai, aiming to leverage the latter's AI-driven drug discovery platform to enhance its oncology pipeline. flag The move positions radiation therapy as a more targeted treatment by integrating advanced molecular analysis. flag The deal, pending final due diligence, could accelerate development of precision cancer therapies.

5 Articles